// STATE LEGISLATION TRACKER

Massachusetts S3212: Amendment S.3212

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Introduced

State: Massachusetts
Bill: S3212
Session: 194th
Filed: 2026-07-23
Read the bill: OpenStates →
Last reviewed: 2026-10-05

Plain-English Summary

Massachusetts S3212 appears to be an animal telehealth amendment tied to S3178, not a human health, pharmacy, compounding, or prescribing bill. Based on the title/status available, it does not appear to change access to compounded peptides, off-label prescribing, NP/naturopath scope, 503A/503B compounding, controlled substances, or PDMP rules.

Key Points

No apparent change to human peptide prescribing or access
No visible impact on compounded peptide rules
No apparent change to NP or naturopath authority
Telehealth relevance appears limited to animal care
Track S3178 only if animal/veterinary peptide use matters

What to Watch For

Note The bill is listed as an amendment with latest action pointing to S3178, so the parent bill controls its fate.

Note If full text later adds pharmacy or veterinary prescribing details, animal-use peptide access could need a separate review.

Note No title or subject signal suggests changes to FDA 503A/503B compounding or controlled substances monitoring.

Where the Bill Stands

S3212 is listed as an amendment with the latest action 'See S3178,' meaning it is being handled through the related parent bill rather than as a standalone peptide policy measure.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws